ERDOS(SH:900936)2021-04-29 16:00Financial Performance - Operating revenue for the period reached CNY 6.76 billion, representing a 55.39% increase year-on-year[7]. - Net profit attributable to shareholders surged by 502.46% to CNY 690.44 million compared to the same period last year[7]. - Basic earnings per share increased to CNY 0.48, up 500% from CNY 0.08 in the same period last year[7]. - The net profit for Q1 2021 reached CNY 916,885,196.27, compared to CNY 153,162,043.17 in Q1 2020, representing a significant increase of 499.2%[32]. - The company’s total profit for Q1 2021 was CNY 1,116,209,083.98, compared to CNY 210,418,949.55 in Q1 2020, marking a rise of 429.5%[32]. - The total comprehensive income for Q1 2021 was CNY 917,071,311.03, significantly higher than CNY 153,760,918.31 in Q1 2020[33]. Cash Flow - The net cash flow from operating activities was CNY 2.19 billion, a significant increase of 2,429.83% year-on-year[7]. - Net cash flow from operating activities for Q1 2021 was ¥2,188,035,780.74, a significant increase of ¥2,101,546,320.37 or 2,429.83% from Q1 2020[20]. - The cash inflow from operating activities for Q1 2021 was CNY 6,531,502,668.67, a significant increase of 139.5% compared to CNY 2,733,105,400.06 in Q1 2020[38]. - The net cash flow from financing activities was negative at CNY -1,740,885,125.93, worsening from CNY -825,158,482.10 in Q1 2020[39]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 46.27 billion, a decrease of 1.13% compared to the end of the previous year[7]. - Total current liabilities decreased to ¥20,715,019,946.70 from ¥22,563,817,850.96 at the end of 2020[25]. - Total liabilities reached CNY 28.55 billion, down by CNY 278.75 million compared to the last reporting period[44]. - The company's equity attributable to shareholders increased to CNY 10,391,072,692.87, compared to CNY 10,310,058,225.70 in the previous period, showing a growth of 0.79%[29]. Research and Development - R&D expenses surged to ¥134,890,301.40, reflecting an increase of ¥123,454,894.20 or 1,079.58% compared to the previous year[16]. - Research and development expenses increased to CNY 134,890,301.40 in Q1 2021, compared to CNY 11,435,407.20 in Q1 2020, reflecting a growth of 1,078.5%[32]. Shareholder Information - The number of shareholders at the end of the reporting period was 72,322[11]. Strategic Focus - The company plans to continue expanding its market presence and investing in new technologies, although detailed strategies were not specified in the earnings call[30]. - The company is focusing on enhancing its operational efficiency and exploring potential mergers and acquisitions to drive future growth[30].